List view / Grid view
28 October 2015 | By Victoria White
Experimentally reducing SGK1 activity in rats induced learned helplessness ( a behaviour thought to mimic one aspect of PTSD), while overexpressing the protein reduced it...
28 October 2015 | By Victoria White
Scientists have demonstrated that medical manipulation of the primary cilia disrupts a key biological process called 'Hedgehog Signalling'...
28 October 2015 | By Victoria White
Under the contract, SRI International will conduct all research and testing necessary to submit Investigational New Drug applications for promising drugs...
27 October 2015 | By Victoria White
Using its proprietary True Human technology, the Company has begun screening human blood samples from donors to identify and clone a therapeutic antibody candidate...
27 October 2015 | By Victoria White
If the researchers blocked a central switch in epileptic mice, the frequency and severity of the seizures decreased...
27 October 2015 | By Victoria White
Testing the system with lung cancer cells, the researchers showed that the ligand-guided protein cages selectively penetrated and killed more than 70% of the cancer cells...
27 October 2015 | By Victoria White
Their "stealth" botulinum neurotoxin programme capitalises on technological advances and promises to bring better drugs, with defined mechanisms of action...
26 October 2015 | By Victoria White
The discovery could shed light on how prostate cancer spreads and provides a possible new target for the disease...
26 October 2015 | By Victoria White
The discovery sheds new light on the role these proteins play in driving cancer cell proliferation...
26 October 2015 | By Victoria White
The collaboration will evaluate the use of CRISPR-Cas9 across multiple diseases, including cystic fibrosis, where targets have been validated through human genetics...
26 October 2015 | By Victoria White
NVC has already initiated research collaborations with two partners to develop a nosocomial vaccine...
26 October 2015 | By Victoria White
The new findings have led to the hypothesis that patients with high levels of CA125 have an immunosuppressive tumour microenvironment that may potentially enable cancer cells to escape immune-mediated cytotoxicity...
26 October 2015 | By Victoria White
The US 9,181,527 Celyad Allogeneic Patent significantly strengthens Celyad’s patent portfolio in the CAR T-Cell field...
23 October 2015 | By Victoria White
The work paves the way for personalised drug discovery for kidney disease...
23 October 2015 | By Victoria White
Using iPSC technology, researchers created 16 different cells lines, some using cells from healthy humans and others using cells from people with ALS or spinal muscular atrophy...
